OncoDaily Pulse

Aug 25, 2025, 14:16

Padraic O’Malley: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

The congress is free to attend.
Register here: https://forms.gle/qcQyaGMQfHDhanfD9

Co-Chair of VIRO

Images Name

Rana McKay
Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
“Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Padraic O’Malley

Dr. Padraic O’Malley is a recognized expert in urologic oncology with a strong focus on optimizing management strategies for patients with localized kidney tumors. His clinical work and research emphasize balancing oncologic control with quality of life through tailored treatment approaches.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. O’Malley will present on “Active Surveillance: Patient Selection and Protocols” as part of the Small Renal Masses and Focal Approaches session. His talk will highlight evidence-based strategies for identifying appropriate candidates for surveillance and developing safe, structured monitoring protocols.

Dr. O’Malley will discuss

Criteria for patient selection in active surveillance of small renal masses.
Best practices in surveillance protocols, including imaging and follow-up.
Case-based insights on balancing surveillance with timely intervention.
Future directions in integrating surveillance with focal therapy approaches.

Through his expertise, Dr. O’Malley emphasizes a patient-centered approach, ensuring that management of small renal masses is both safe and individualized.